Pediatr Gastroenterol Hepatol Nutr.  2020 Mar;23(2):132-136. 10.5223/pghn.2020.23.2.132.

Effect of a Gluten Free Diet on Hepatitis B Surface Antibody Concentration in Previously Immunized Pediatric Celiac Patients

• Zifman E
• Zevit N
• Heshin-Bekenstein M
• Turner D
• Shamir R
• Silbermintz A

• KMID: 2471622
• DOI: http://doi.org/10.5223/pghn.2020.23.2.132

Abstract

PURPOSE
To evaluate the effect of gluten-free diet (GFD) on hepatitis B surface antibody (HBsAb) concentrations among previously immunized pediatric celiac disease (CD) subjects.
METHODS
We retrospectively evaluated pediatric CD subjects in serological remission who were previously immunized for hepatitis B virus as infants. The temporal relationship between HBsAb concentration, the amount of time on a GFD, and age were evaluated.
RESULTS
Overall, 373 CD subjects were analyzed: 156 with HBsAb sampled prior to GFD initiation and 217 after initiation of a GFD and in serological remission. Median age at HBsAb concentration measurement for those before and after GFD initiation was 5.3 years (interquartile range [IQR], 3.1-9.2 years) and 7.6 years (IQR, 5.4-10.9 years), respectively (p<0.001). There was no sex difference between the groups. The median time of HBsAb measurement was 2 months (IQR, 0-5.7 months) before and 12.8 months (IQR, 5.3-30.3 months) after initiation of GFD. The HBsAb concentration was low in 79 (50.6%) and 121 (55.7%) subjects before and after GFD initiation, respectively (p=0.350). Age was inversely associated with low HBsAb concentrations. Neither being on a GFD nor sex was associated with low HBsAb concentrations.
CONCLUSION
Adherence to a GFD does not affect HBsAb concentration in children with CD. Age is inversely associated with HBsAb concentration.

Keyword

Antibodies; Immunization; Serology; Child

MeSH Terms

Antibodies
Celiac Disease
Child
Diet, Gluten-Free*
Glutens*
Hepatitis B virus
Hepatitis B*
Hepatitis*
Humans
Immunization
Infant
Retrospective Studies
Sex Characteristics
Antibodies
Glutens

Reference

1. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018; 16:823–836.e2. PMID: 29551598.

2. Sansotta N, Amirikian K, Guandalini S, Jericho H. Celiac disease symptom resolution: effectiveness of the gluten-free diet. J Pediatr Gastroenterol Nutr. 2018; 66:48–52. PMID: 28514243.

3. Green PH, Krishnareddy S, Lebwohl B. Clinical manifestations of celiac disease. Dig Dis. 2015; 33:137–140. PMID: 25925914.

4. Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986; 315:209–214. PMID: 2941687.

5. Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, et al. Centers for Disease Control and Prevention (CDC). CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013; 62(RR-10):1–19.

6. Park SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007; 44:431–435. PMID: 17414139.

7. Ertekin V, Tosun MS, Selimoglu MA. Is there need for a new hepatitıs B vaccine schedule for children with celiac disease? Hepat Mon. 2011; 11:634–637. PMID: 22140387.

8. Zingone F, Morisco F, Zanetti A, Romanò L, Portella G, Capone P, et al. Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. Vaccine. 2011; 29:1005–1008. PMID: 21129395.

9. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis. ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012; 54:136–160. PMID: 22197856.

10. Katoonizadeh A, Sharafkhah M, Ostovaneh MR, Norouzi A, Khoshbakht N, Mohamadkhani A, et al. Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study. J Viral Hepat. 2016; 23:805–811. PMID: 27126365.

11. Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016; 214:16–22. PMID: 26802139.

12. Hadi N, Hadi N. Assessment of anti-HBs antigen in 6- to 9-year-old children routinely vaccinated via vaccination program in Iran. Med Princ Pract. 2007; 16:306–309. PMID: 17541297.

13. Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics. 2007; 120:e373–81. PMID: 17636112.

14. Heshin-Bekenstein M, Turner D, Shamir R, Bar-Meir M, Dagan R, Zevit N, et al. Hepatitis B virus revaccination with standard versus pre-S vaccine in previously immunized patients with celiac disease. J Pediatr Gastroenterol Nutr. 2015; 61:400–403. PMID: 25988560.

15. Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, La Rosa M. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol. 2012; 18:5729–5733. PMID: 23155313.

16. Nemes E, Lefler E, Szegedi L, Kapitány A, Kovács JB, Balogh M, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008; 121:e1570–6. PMID: 18519462.